Arcutis Biotherapeutics (ARQT) Short-term Investments (2019 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Short-term Investments of $189.2 million for Q1 2026, up 30.52% year-over-year from $145.0 million in Q1 2025, and up 6.27% quarter-over-quarter from $178.1 million in Q4 2025.
Arcutis Biotherapeutics (ARQT) Short-term Investments (2019 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Short-term Investments history runs 8 years deep, the most recent figure standing at $189.2 million for Q1 2026.
- In Q1 2026, Short-term Investments rose 30.52% year-over-year to $189.2 million; the TTM figure through Mar 2026 stood at $189.2 million (up 30.52% YoY), while the FY2025 annual figure was $178.1 million, up 13.7% from the prior year.
- Short-term Investments for Q1 2026 stood at $189.2 million, up from $178.1 million in the prior quarter.
- The five-year high for Short-term Investments was $395.4 million in Q3 2022, with the low at $118.1 million in Q2 2025.
- The 5-year median for Short-term Investments is $189.2 million (2026), against an average of $210.7 million.
- The sharpest annual moves came in 2022 and 2023: Short-term Investments surged 75.25% in 2022, then slumped 69.74% in 2023.
- Arcutis Biotherapeutics' Short-term Investments stood at $355.9 million in 2022, then sank by 48.46% to $183.5 million in 2023, then decreased by 14.63% to $156.6 million in 2024, then climbed by 13.7% to $178.1 million in 2025, then advanced by 6.27% to $189.2 million in 2026.
- Business Quant data shows ARQT's Short-term Investments at $189.2 million in Q1 2026, $178.1 million in Q4 2025, and $143.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 204.43 Mn |
| Mar 31, 2026 | 189.24 Mn |
| Dec 31, 2025 | 178.08 Mn |
| Sep 30, 2025 | 143.95 Mn |
| Jun 30, 2025 | 118.08 Mn |
| Mar 31, 2025 | 144.98 Mn |
| Dec 31, 2024 | 156.62 Mn |
| Sep 30, 2024 | 195.71 Mn |
| Jun 30, 2024 | 278.17 Mn |
| Mar 31, 2024 | 213.77 Mn |
| Dec 31, 2023 | 183.46 Mn |
| Sep 30, 2023 | 119.64 Mn |
| Jun 30, 2023 | 163.56 Mn |
| Mar 31, 2023 | 251.00 Mn |
| Dec 31, 2022 | 355.95 Mn |
| Sep 30, 2022 | 395.42 Mn |
| Jun 30, 2022 | 220.66 Mn |
| Mar 31, 2022 | 273.81 Mn |
| Dec 31, 2021 | 290.61 Mn |
| Sep 30, 2021 | 315.49 Mn |